Sensitive ASX Announcement

PTX-100 CTCL Phase 2a study reaches review milestone

Published: 02/09/26, 02:10pm (AEST)•3 pages
Prescient Therapeutics
PTX:ASX•Healthcare

Recent PTX Announcements

Price Sensitive only